Gaza Health Ministry: 94 Palestinians killed as Israel targets kill zones
At least 94 Palestinians were killed as Israeli air and artillery strikes continued across Gaza, the strip's Ministry of Health announced on Wednesday.
According to the ministry, 7,750 people have been killed and 27,566 injured since March 18, when Israel withdrew from ceasefire negotiations. An additional 910 fatalities and more than 5,500 injuries have been recorded since May 27, when Israeli forces began targeting aid distribution points—areas that local authorities and rights groups now describe as 'kill zones.'
The ministry reported that the overall toll since the beginning of the war has reached 58,573 dead and over 139,600 injured, with approximately 11,000 people still missing under the rubble.
The figures come amid a sharp escalation in military operations across the enclave. The Euro-Med Human Rights Monitor reported that nearly 45% of Khan Younis is now under Israeli fire, with civilians increasingly treated as 'terrorist targets.'
The group also warned that the ongoing isolation of eastern Khan Younis reflects what it described as a 'colonial tool' aimed at fragmenting Gaza both geographically and demographically. It further condemned the scale of destruction in the area as lacking military necessity and violating international law.
Meanwhile, the United Nations Relief and Works Agency (UNRWA) recorded a sharp rise in child malnutrition since March, when Israeli authorities imposed a total blockade on humanitarian aid entering Gaza.
Despite critical shortages, UNRWA medical teams continue to operate in the field, providing nutritional assessments and treatment for vulnerable children. A joint aid convoy organized by the World Health Organization (WHO) and the United Nations Children's Fund (UNICEF) is also expected to enter Gaza on Thursday.
According to Gaza's Health Ministry, the trucks will carry medical supplies and child vaccination materials. No food aid is included in the shipment.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Iraqi News
7 hours ago
- Iraqi News
France's Sanofi helps Iraq develop pharmaceutical industry
Baghdad ( – The Iraqi Ministry of Health mentioned on Sunday that the agreement with Sanofi, a French pharmaceutical and healthcare company, represents an essential step toward strengthening Iraq's pharmaceutical industry. During his participation in a scientific workshop on biosimilar medicines and intellectual property, Deputy Health Minister Hani al-Oqabi explained that the agreement reached with Sanofi is not limited to the pharmaceutical industry but includes other important areas, according to the state-run news agency (INA). Iraqi Prime Minister Mohammed Shia al-Sudani has lately been focusing on developing collaboration with international enterprises and seeking investments to build industries in Iraq, according to al-Oqabi. The prime minister's advisor on industry and private sector development, Hammoudi al-Lami, revealed earlier that AstraZeneca, a British-Swedish multinational pharmaceutical and biotechnology company based in Cambridge, is thinking of building a pharmaceutical facility in Iraq. In a statement to the Iraqi News Agency (INA), al-Lami explained that Arab and foreign companies are eager to set up businesses in the Iraqi market. The Iraqi official indicated that the US multinational healthcare company Baxter, as well as businesses in the Gulf States, had also expressed a desire to become part of the Iraqi market. The Iraqi Ministry of Health revealed in late April that it signed an agreement with European companies to establish an insulin production plant in the northern Iraqi province of Nineveh. According to INA, the agreement was signed with a Polish firm, one of the top four producers of insulin worldwide, and a German corporation. The idea to produce insulin in Iraq that meets all European requirements was sparked by the Iraqi government's support for pharmaceutical and health industry initiatives. The steps align with the objectives outlined in the Iraqi government's agenda, which emphasizes the development of the country's health sector.
Shafaq News
11 hours ago
- Shafaq News
UK experts: ChatGPT may worsen psychosis
Shafaq News – London AI chatbots like ChatGPT could worsen psychosis in vulnerable users, UK mental health experts caution, as reliance on AI for emotional support surges. In a paper cited by The Telegraph, NHS psychiatrists and academic researchers warned that AI tools may trigger or intensify psychosis in vulnerable users by reinforcing delusions through uncritical engagement. The authors explained that individuals with early psychotic symptoms could misread chatbot replies as confirmation of distorted beliefs, with no clinical guardrails to intervene. The warning comes amid surging AI adoption, with ChatGPT alone downloaded over 900 million times, according to the report. The findings escalate the debate over AI in mental health, as supporters promote these tools for expanding access while critics demand strict oversight to prevent harm where artificial interaction risks substituting for clinical care.
Shafaq News
15 hours ago
- Shafaq News
Iraq, Sanofi partner to boost healthcare
Shafaq News – Baghdad Iraq's Ministry of Health signed a memorandum of understanding with French pharmaceutical company Sanofi on Sunday to expand medical training, combat counterfeit medicines, and modernize the country's healthcare system. Speaking at a forum on biosimilar medicines and intellectual property, Deputy Health Minister Hani Al-Oqabi framed the agreement as part of a broader strategy to engage global health institutions and apply international expertise in Iraq. 'The deal goes beyond pharmaceuticals,' he noted. 'It includes workforce development, nursing programs, and coordinated efforts to counter the spread of fake medicines.' Al-Oqabi highlighted Prime Minister Mohammed Shia Al-Sudani's push to attract foreign investment, particularly in pharmaceuticals, crediting the national program with recent advances in facility upgrades and workforce expansion. Rami Nassar, Head of Sanofi's Near East Pharmaceutical Unit and Director of its Jordan office, drew attention to the company's integration of artificial intelligence in research and development, with a focus on improving patient outcomes. He also outlined the 'Imkan' initiative, launched in Iraq in February, which introduced a structured approach to health system support—from training on health technology assessment to sharing case studies from nearby countries. 'We've completed two phases of the agreement and will begin the third in September, focusing on training for nurses and allied health professionals,' Nassar confirmed, adding that the final stage, planned for the end of the year, will center on health economics.
